Novozymes A/S's ticker is NVZMY and the CUSIP is 670108109. A total of 8 filers reported holding Novozymes A/S in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $24,000 | +4.3% | 395 | +21.2% | 0.02% | +260.0% |
| Q1 2022 | $23,000 | -14.8% | 326 | +0.6% | 0.01% | -16.7% |
| Q4 2021 | $27,000 | +17.4% | 324 | -1.8% | 0.01% | +20.0% |
| Q3 2021 | $23,000 | -8.0% | 330 | -1.8% | 0.01% | -16.7% |
| Q2 2021 | $25,000 | +13.6% | 336 | -2.0% | 0.01% | +20.0% |
| Q1 2021 | $22,000 | +10.0% | 343 | +0.6% | 0.01% | +25.0% |
| Q4 2020 | $20,000 | +233.3% | 341 | +244.4% | 0.00% | +300.0% |
| Q3 2020 | $6,000 | 0.0% | 99 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | +20.0% | 99 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | -89.6% | 99 | -91.2% | 0.00% | -88.9% |
| Q3 2019 | $48,000 | +4.3% | 1,130 | +23.4% | 0.01% | -10.0% |
| Q2 2019 | $46,000 | -6.1% | 916 | -13.5% | 0.01% | +11.1% |
| Q1 2019 | $49,000 | +11.4% | 1,059 | +8.1% | 0.01% | 0.0% |
| Q4 2018 | $44,000 | -12.0% | 980 | +7.0% | 0.01% | -10.0% |
| Q3 2018 | $50,000 | +8.7% | 916 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $46,000 | -4.2% | 916 | 0.0% | 0.01% | -9.1% |
| Q1 2018 | $48,000 | -7.7% | 916 | 0.0% | 0.01% | -8.3% |
| Q4 2017 | $52,000 | – | 916 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ZEVIN ASSET MANAGEMENT LLC | 57,209 | $2,887 | 0.63% |
| Boston Common Asset Management, LLC | 18,413 | $930 | 0.04% |
| GOFEN & GLOSSBERG LLC /IL/ | 5,000 | $252 | 0.01% |
| MAR VISTA INVESTMENT PARTNERS LLC | 273 | $13,776 | 0.00% |
| ST GERMAIN D J CO INC | 5,000 | $252 | 0.00% |
| PNC FINANCIAL SERVICES GROUP, INC. | 3,075 | $155,297 | 0.00% |
| Financial Avengers, Inc. | 10 | $505 | 0.00% |